Atlassian introduced monthly AI spending 'wallets' of up to $2,000 per employee to track and cap AI use, while other tech companies encourage unrestrained use known as 'tokenmaxxing'. The move follows Atlassian citing AI costs in its decision to cut 1,600 jobs.
Atlassian, founded by Mike Cannon-Brookes and Scott Farquhar, is one of Australia's largest software companies, known for products like Jira, Confluence, and Trello. The company recently restructured, cutting 1,600 jobs while citing AI as both an opportunity and a cost factor. The broader tech industry has been grappling with how to manage spiralling AI compute costs.
Corporate AI spending is exploding as companies race to adopt generative AI tools. Atlassian's approach represents an alternative to the 'move fast and spend freely' philosophy dominant in Silicon Valley, and may serve as a model for companies seeking to balance AI adoption with cost control. The outcome could influence how enterprises manage AI budgets across the economy.

Atlassian introduced monthly AI spending 'wallets' of up to $2,000 per employee to track and cap AI use, while other tech companies encourage unrestrained use known as 'tokenmaxxing'. The move follows Atlassian citing AI costs in its decision to cut 1,600 jobs.

Atlassian, founded by Mike Cannon-Brookes and Scott Farquhar, is one of Australia's largest software companies, known for products like Jira, Confluence, and Trello. The company recently restructured, cutting 1,600 jobs while citing AI as both an opportunity and a cost factor. The broader tech industry has been grappling with how to manage spiralling AI compute costs.

Corporate AI spending is exploding as companies race to adopt generative AI tools. Atlassian's approach represents an alternative to the 'move fast and spend freely' philosophy dominant in Silicon Valley, and may serve as a model for companies seeking to balance AI adoption with cost control. The outcome could influence how enterprises manage AI budgets across the economy.

πŸ“° Source: Guardian AU
theguardian.com β†—
Was this article useful?